Skip to main content
. 2022 Jun 11;20:265. doi: 10.1186/s12967-022-03469-6

Table 3.

The heterogeneous features for test data (710 cases) according to blood tests

Features Cluster one Cluster two Cluster three Cluster four P value
Number of clusters 90 520 19 81
survival (%) 68 (75.56%) 416 (80%) 13 (68.42%) 57 (70.37%) 0.152
Age, median (IQR), y 64 (51.5–77.5) 66 (54–77) 60 (51.3–69.3) 65 (54–74) 0.364
Male, no. (%) 55 (61.11%) 296 (56.92%) 12 (63.16%) 49 (60.49%) 0.797
Top ten blood test varies, median (IQR), unit
 PTT, sec 31.7 (27.7–36.5) 30.1 (26.6–34.2) 150 (119.0–150) 50.5(43.6–57.7) 0.000
 Neutrophils, % 52 (36.3–61.7) 83 (77–88.7) 81 (70.2–87.5) 81 (76.9–88.6) 0.000
 PT, sec 14.4 (13.3–17.1) 14.3 (13.1–16.3) 19.5 (15.4–23.1) 28 (19.6–39) 0.000
 INR(PT), NULL % 1.3 (1.2–1.7) 1.3 (1.1–1.6) 1.9 (1.6–2.7) 3 (2–4.3) 0.000
 Lymphocytes, % 27.1 (18.5–35.3) 7.1 (4–11.9) 9.7 (3.7–11) 7.2 (3–12) 0.000
 White blood cells, K/μL 4.7 (2.8–10.3) 13.0 (8.4–18.4) 9.6 (7.4–18.2) 12.4 (8.2–19.2) 0.000
 Platelet count, K/μL 2.2 (1.9–2.5) 2.4 (2.2–2.5) 2.4 (2.1–2.6) 2.3 (2.2–2.5) 0.000
 MCHC, % 33.4 (32.3–34.6) 33 (32–34) 32.7 (30.5–33.6) 32.5 (31.2–33.6) 0.000
 Albumin, % 2.9 (2.6–3.4) 2.9 (2.6–3.4) 2.9 (2.8–2.9) 2.6 (2.3–3) 0.000
 Red blood cells, K/μL 3.4 (3.0–4.0) 3.7 (3.3–4.3) 3.8 (3.4–4.0) 3.5 (2.9–3.9) 0.000